Paradromics Inc.

Speech BCIs are moving from proof of concept toward something people can live with outside the lab. A recent article from @ScienceNews traces the field from the first decoded words to fully implantable systems now in clinical study, including the investigational Connexus® BCI.

Read more: sciencenews.org/article/brain-…

The FDA approved an amendment to our Connect-One study protocol: participants no longer need to live within a four-hour drive of a clinical site. Eligible people across the U.S. may now be evaluated for the investigational Connexus BCI, if they can travel to a site.

Read more: paradromics.com/news/paradromi…

The Austin Business Journal recently profiled our founder and CEO @Matt_R_Angle: on leading ethically in BCI, roasting coffee in the garage, and the one book every founder should read.

Read more: bizjournals.com/austin/news/20…

@MyABJ

Today, we announced a collaboration with @SiemensHealth to build an end-to-end imaging workflow for implantable BCIs.

Through our partnership, structural MRI, functional MRI, vascular imaging, and CT scanning will now be combined to form one end-to-end process, from patient assessment and surgical planning to implantation and long-term outcomes.

Read the full announcement: paradromics.com/news/paradromi…

How far can human intention reach? At Abundance Longevity, founder and CEO @Matt_R_Angle introduced the Intent Horizon – that as neural interfaces, AI agents, and robotic systems grow in capability, the distance between what a person intends and what they can do will start to narrow, expanding the boundaries of what people can accomplish.

Thank you to @PeterDiamandis and @Abundance360.